The CDMO Sector Holds a Core Position in the Pharmaceutical Industry As a major part of the outsourcing pharmaceutical service industry, CDMOs support pharmaceutical companies across the entire chain, ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Simcere Pharmaceutical Group Ltd, a Nanjing, Jiangsu province-headquartered drugmaker, plans to expand its global presence ...
Today, China ranks second only to the United States in the number of new drugs under development, with its pipeline accounting for more than one-fifth of the global total. Since 2021, over 110 ...
Africa’s pharmaceutical sector is witnessing an influx of foreign interest, with Chinese companies leading the charge. This surge comes as Africa’s $25bn pharmaceutical market continues to grow, ...
Qilu Pharmaceutical is paying 280 million Chinese yuan ($38 million) for a licensing and collaboration deal with fellow China biopharma Minghui Pharmaceutical. The pact centers on MHB088C, a ...
A hand holds up a tamper-safe orange bottle filled with oblong white pills against a red-tinted background of Chinese yuan. As China’s biopharmaceutical industry churns out more innovative molecules, ...
A little over a decade ago, a class of drugs to treat blood cancers arrived on the scene. Known as BTK inhibitors, they block a key enzyme needed by cancer cells to survive. “These drugs turn the ...
China Resources Pharmaceutical Group Ltd. ( ($HK:3320) ) has shared an announcement. China Resources Pharmaceutical Group has completed the ...
Looking ahead to November’s election, trade policy forms a core fixture for both parties. Both the GOP and Democratic Party have expressed support for tariffs with a common set of objectives in mind: ...
TipRanks on MSN
Shandong Xinhua Pharmaceutical wins China approval for valsartan hypertension capsules
An announcement from Shandong Xinhua Pharmaceutical Company Limited Class H ( ($HK:0719) ) is now available. Shandong Xinhua Pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results